Reforming Intellectual Property Law?
Lots of people say IP law in the U.S. needs to be reformed. The usual complaint is that IP is skewed towards the interests of mass media at the expense of creators and users. There exist various proposals to reduce the period of IP protection and otherwise cut back on rights. These proposals are unlikely to succeed: Congress tends to expand not reduce IP rights.\n\nI propose a different fix: stopping overreaching. Overreaching is when somebody uses IP to claim rights beyond those the law confers. E.g. reprints of public domain materials (Shakespeare’s plays, The Federalist, old paintings) carry false copyright notices. Fair use is wrongly denied. Trademark is claimed where it doesn’t exist. \n\nRather than cut back on the scope of rights, let’s work on keeping rights within the confines the law sets.\n\nHow to do it? Will it work? \n\nI am writing a book on this topic. Some initial thoughts here:\nhttp://papers.ssrn.com/sol3/papers.cfm?abstract_id=787244#PaperDownload
It's unlikely that there's anything on the planet that is worth the cost of shipping it back
- Privatized mining on both Mars and the Moon is likely to occur in the next century
Moon rock on display at US Space and Rocket Center, Huntsville, AL (Big Think/Matt Carlstrom)In 1973, NASA valuated moon rocks at $50,800 per gram –– or over $300,000 today when adjusted for inflation. That figure doesn't reflect the value of the natural resources within the rock, but rather the cost of their extraction.
Researchers believe that the practice of sleeping through the whole night didn’t really take hold until just a few hundred years ago.
She was wide awake and it was nearly two in the morning. When asked if everything was alright, she said, “Yes.” Asked why she couldn’t get to sleep she said, “I don’t know.” Neuroscientist Russell Foster of Oxford might suggest she was exhibiting “a throwback to the bi-modal sleep pattern." Research suggests we used to sleep in two segments with a period of wakefulness in-between.
Antimicrobial resistance is growing worldwide, rendering many "work horse" medicines ineffective. Without intervention, drug-resistant pathogens could lead to millions of deaths by 2050. Thankfully, companies like Pfizer are taking action.
- Antimicrobial-resistant pathogens are one of the largest threats to global health today.
- As we get older, our immune systems age, increasing our risk of life threatening infections. Without reliable antibiotics, life expectancy could decline for the first time in modern history.
- If antibiotics become ineffective, common infections could result in hospitalization or even death. Life-saving interventions like cancer treatments and organ transplantation would become more difficult, more often resulting in death. Routine procedures would become hard to perform.
- Without intervention, resistant pathogens could result in 10 million annual deaths by 2050.
- By taking a multi-faceted approach—inclusive of adherence to good stewardship, surveillance and responsible manufacturing practices, as well as an emphasis on prevention and treatment—companies like Pfizer are fighting to help curb the spread.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.